Selective Serotonin Reuptake Inhibitors are a mainstay in the management of depression and other mental health disorders. All SSRIs are not created equal and when I am reviewing a patient case, I make sure to look for specific things that may put a patient at risk for...
I have been receiving questions on occasion regarding asthma therapy. More specifically, with the GINA recommendations, should SABA ever be used in asthma? Many are confused about what we should be doing for acute asthma relief. In my opinion, this confusion comes...
When I was in school, acetaminophen was considered the go agent for the management of osteoarthritis pain. While acetaminophen in osteoarthritis is still possibly a 2nd or 3rd line consideration, more evidence has come to light over the years that maybe it really...
Azathioprine isn’t a drug I see terribly often in clinical practice, but there are some really important things to remember. I recently put together a podcast on azathioprine and I wanted to share some of my top azathioprine clinical pearls with you....
In clinical practice, I don’t see biologics in asthma very often, but it is something that I think is important to remember. The most commonly used agent over the years that I have seen is omalizumab (Xolair). According to the GINA guidelines, patients that have...
Statin myopathy is a primary reason why patients stop taking these cholesterol-lowering medications. Here’s a case scenario where I discuss considerations and options to addressing statin myopathy and adverse effect concerns from a patient. SE is a 58-year-old...
